Hemant Dhamne

Head of Process Development – Gene Therapy Vector Facility • King’s College London

Dr. Hemant Dhamne is an expert in the field of cell and gene therapy with specific experience in building and operating Product, Process, Analytical Development, and Manufacturing functions.

He has done a Ph.D. in Viral Vectors/Gene Therapy followed by a Postdoc in Functional Genomics. Later he has worked with Intas Pharmaceuticals for AAV Gene Therapy and most recently with Immuneel Therapeutics for CAR-T cell therapy. He also holds a diploma in International Business and Medical Diagnostics. At present, he is heading the Process Development function at Gene Therapy Vector Facility, King’s College London.

He has previously led the team delivering pre-IND & IND applications for AAV-8 FIX, AAV8-FVIII, and CD19-CAR T products. He built the capability and infrastructure for cell and gene therapy in India and was the key person to bring the CGT wave to his country.

Besides this, Hemant also indulges in Indian classical music, learning vocals and bamboo flute.

Also speaking

Frank Thielmann

Head Lean – Global Operational Excellence • Takeda

Tim Funnell

Partner • Monograph Capital

Catriona Crombie

Associate Director of Technology Transfer • LifeArc

Event Info


Sponsorship Brochure

Take a look at the 2023 sponsorship opportunities here.

Agenda at a Glance

Check out the Agenda at a Glance for Advanced Therapies Europe 2023.